Carboxypeptidase E is a prediction marker for tumor recurrence in early-stage hepatocellular carcinoma

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Shiu-Feng HuangY Peng Loh

Abstract

Tumor recurrence and metastasis are the major causes of death for hepatocellular carcinoma (HCC) patients who are able to receive curative resection. Identifying the predicting biomarkers for tumor recurrence would improve their survival. RNA extracted from fresh frozen tumors and adjacent non-tumor liver tissues of 120 HCC patients were obtained from Taiwan Liver Cancer Network (TLCN) in year 2010 for determination of the carboxypeptidase E (CPE) expression level (including its splicing mutant CPE-ΔN) in the tumor tissue (T) and paired non-tumor liver tissue (N) by real-time quantitative polymerase chain reaction. All patients were male, had chronic hepatitis B virus infection, were in the early pathology stage, and received curative resection. The T/N ratio of the CPE expression level was correlated with the updated survival data from TLCN in 2015. The CPE expression level in the 120 HCC patients was divided into three groups according to the T/N ratio: <1, ≥1 and ≤2, and >2, respectively. By multivariate analyses, the recurrence-free survival (RFS) was only significantly associated with the pathology stage and the CPE expression level. For overall survival (OS), only the CPE expression level was the significant prognostic fa...Continue Reading

References

Jan 1, 1988·Annual Review of Physiology·L D Fricker
May 27, 2005·Seminars in Liver Disease·Josep M LlovetVincenzo Mazzaferro
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
Feb 12, 2009·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Ming-Wei LaiChau-Ting Yeh
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
Oct 19, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shinji TanakaShigeki Arii
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Mar 10, 2012·Endocrine Reviews·Niamh X CawleyY Peng Loh
Jul 16, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Kun ZhouXiaofeng Jiang
Aug 15, 2013·Cancer Letters·Saravana R K MurthyY Peng Loh
Nov 5, 2014·Seminars in Liver Disease·Li-Chun LuRonnie T P Poon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.